Cargando…
Histone modification and histone modification-targeted anti-cancer drugs in breast cancer: Fundamentals and beyond
Dysregulated epigenetic enzymes and resultant abnormal epigenetic modifications (EMs) have been suggested to be closely related to tumor occurrence and progression. Histone modifications (HMs) can assist in maintaining genome stability, DNA repair, transcription, and chromatin modulation within brea...
Autores principales: | Feng, Jianwei, Meng, Xinyue |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9522521/ https://www.ncbi.nlm.nih.gov/pubmed/36188615 http://dx.doi.org/10.3389/fphar.2022.946811 |
Ejemplares similares
-
Mechanism and Therapeutic Opportunities of Histone Modifications in Chronic Liver Disease
por: Cai, Qiuyu, et al.
Publicado: (2021) -
Epigenetic modifications of histones in cancer
por: Zhao, Zibo, et al.
Publicado: (2019) -
Targeting Histone Modifications in Breast Cancer: A Precise Weapon on the Way
por: Li, Wei, et al.
Publicado: (2021) -
Global histone modifications in breast cancer and their prognostic significance
por: Green, AR, et al.
Publicado: (2006) -
Crosstalk of Histone and RNA Modifications Identified a Stromal-Activated Subtype with Poor Survival and Resistance to Immunotherapy in Gastric Cancer
por: Yuan, Cheng, et al.
Publicado: (2022)